Neuromodulation for Hoarding Disorder and Depression
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial requires that you stay on your current psychiatric medications if they have been stable for 6 weeks, and no changes are expected during the study period. However, if you are taking lorazepam 2 mg or greater daily (or benzodiazepine equivalent), any anticonvulsant, or medication that lowers seizure threshold, you may not be eligible to participate.
What data supports the idea that Neuromodulation for Hoarding Disorder and Depression is an effective treatment?
The available research shows that intermittent theta burst stimulation (iTBS) has shown promise in treating depression, particularly in cases where other treatments have failed. For example, a study found that iTBS was effective for treatment-resistant depression, with most patients experiencing improvement, although the effects were not long-lasting. Another study highlighted that iTBS over a specific brain area showed promise in open-label trials for depression. While these studies focus on depression, they suggest that iTBS could be a promising treatment option for related conditions like hoarding disorder.12345
What safety data exists for iTBS treatment?
iTBS, or intermittent theta burst stimulation, has been studied for its safety and efficacy in treating various psychiatric disorders, including depression and bipolar depression. Studies have generally reported that iTBS is safe and well-tolerated, with mild adverse effects and no cases of seizures or mania. Specific studies have shown that iTBS is safe for use in major depressive disorder, bipolar depression, and treatment-resistant depression, with no significant adverse events observed. However, some participants have experienced tolerability issues, and further research is needed to confirm long-term safety and efficacy.678910
Is iTBS a promising treatment for hoarding disorder and depression?
iTBS, a noninvasive brain stimulation treatment, shows promise for depression. It is effective, fast-acting, and safe, with potential improvements through multiple daily sessions and precise targeting. This makes it a promising option for treating depression, which could also benefit hoarding disorder.124611
What is the purpose of this trial?
The primary goal of this study is to evaluate whether intermittent theta burst stimulation (iTBS) is effective for treating depression in people who have depression and chronic hoarding disorder (HD). The study will also evaluate whether this treatment can improve HD symptoms, cognitive performance, and brain region connectivity. The study team will investigate how the treatment works for depression, as well as other factors that can enhance or hinder treatment, such as pre-treatment level of depression, cognitive performance, or brain region connectivity.
Research Team
Elizabeth Twamley, PhD
Principal Investigator
UC San Diego
Eligibility Criteria
This trial is for adults aged 18-70 with both depression and hoarding disorder, who have been stable on psychiatric meds for 6 weeks. They must be able to commit to the treatment schedule, complete assessments in English, and not have any MRI or TMS contraindications. Pregnant individuals or those with certain neurological conditions or high suicide risk are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- iTBS
iTBS is already approved in United States for the following indications:
- Treatment-resistant depression
- Major depressive disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor